Do you ever wonder what motivates your physician to order certain drugs or use certain devices? The government constantly evaluates what influences drug and device orders as it attempts to reduce the costs to the Medicare and Medicaid Program. One area of focus has always been and will continue to be physician financial relationships with the drug and device manufacturers. In furtherance of this scrutiny and in conformance with the Healthcare Reform Act requirements, on February 8, 2013, the Physician Payment Sunshine Act (“Sunshine Act”) was finalized and published. The Sunshine Act will provide public awareness of physicians’ financial relationships with manufacturers and drug companies.
The Sunshine Act specifically requires manufacturers of certain drugs, devices, as well as biological and medical suppliers to provide an annual report of any direct or indirect payments to physicians. A payment means, a payment that may be in excess of $10.00 and it could include